Suppr超能文献

肝细胞癌手术切除后复发的积极管理。

Aggressive management of recurrence following surgical resection of hepatocellular carcinoma.

作者信息

Farges O, Regimbeau J M, Belghiti J

机构信息

Department of Hepato-biliary and Digestive Surgery, Beaujon Hospital, University Paris VII, Clichy, France.

出版信息

Hepatogastroenterology. 1998 Aug;45 Suppl 3:1275-80.

PMID:9730388
Abstract

BACKGROUND

Liver resection of hepatocellular carcinoma (HCC) is associated with a high incidence of recurrence, that has a poor prognosis.

AIM

Assess the rationale for and result of an aggressive treatment of recurrence following resection of HCC.

METHODOLOGY

Retrospective analysis of 132 patients with recurrent HCC with special reference to the topography and time of onset of recurrence as well as outcome following treatment of these recurrences. Case-control analysis of the efficacy of repeat hepatectomy and its influence on the long term prognosis of patients with recurrent tumor.

RESULTS

Sixty seven percent of the recurrences were exclusively intrahepatic and half of these were limited in size and number. The 5-year survival rate following treatment of limited intrahepatic recurrence by repeat hepatectomy, arterial chemoembolization or percutaneous ethanol injection was 30%. Repeat hepatectomies improved the long term outcome of patients with recurrent HCC.

CONCLUSION

An aggressive approach to tumor recurrence is currently the best way to improve the long term outcome following resection of HCC.

摘要

背景

肝细胞癌(HCC)肝切除术后复发率高,预后较差。

目的

评估HCC切除术后积极治疗复发的理论依据及结果。

方法

回顾性分析132例复发性HCC患者,特别关注复发的部位、时间以及这些复发灶治疗后的结果。对再次肝切除术的疗效及其对复发性肿瘤患者长期预后的影响进行病例对照分析。

结果

67%的复发仅局限于肝内,其中一半在大小和数量上有限。通过再次肝切除术、动脉化疗栓塞或经皮乙醇注射治疗局限性肝内复发后的5年生存率为30%。再次肝切除术改善了复发性HCC患者的长期预后。

结论

目前,积极应对肿瘤复发是改善HCC切除术后长期预后的最佳方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验